06 Sep SAKSIA’S STORY
In the busy time leading up to Christmas, Saskia, a usually healthy and happy toddler (22 months) developed a slight temperature. It didn’t seem to be anything to worry about at first with their family GP’s advising to treat it with Neurofen/Paracetamol. But after Christmas the fever was still there and Saskia was getting weaker. Their GP’s advised them to present to an emergency room and Saskia was admitted for a suspected ear infection and discharged five days later in the hope that a stronger course of antibiotics would reduce the fever. However, the fever wasn’t responding to the medication and Saskia’s parents, Stephanie and Duane, knew something wasn’t right. In consultation with the GP’s and the initial hospital they took Saskia to the Emergency Department at Sydney Children’s Hospital, Randwick. As soon as she arrived, the expert staff began to run tests to find out what was wrong.
An initial chest x-ray followed by an MRI scan revealed devastating news. Saskia had an aggressive cancerous tumour called a Neuroblastoma. It was stage four and had already metastasized, meaning it had spread to other parts of her body including her skull, jaw and pelvis.
“We couldn’t believe what we were hearing,”says Stephanie. “It was terrifying. Everything just started to move so fast – like a whirlwind.”
Clinicians from the Kids Cancer Centre (KCC) at Sydney Children’s Hospital, Randwick had completed a clinical trial in stage four Neuroblastoma called the SIOPEN study, which was funded by the Australian Lions Children’s Cancer Foundation (ALCCRF). Findings from this research meant that doctors knew the very best course of action to take for Saskia.
A 15-month treatment plan was designed specifically to combat her type of cancer. First, she had a biopsy and more scans to determine the extent of the disease. She was then scheduled for surgery to have a central line inserted, so she could begin chemotherapy. Saskia would need eight rounds of chemo in quick succession. The SIOPEN study revealed that this was possible if combined with special injections (GCSF) to protect her immune system.
“It was such difficult time. Saskia now needed 24/7 care and her younger brother, Vincent, also needed lots of care as he was only one month old. The chemo made her incredibly unwell and the schedule was gruelling but we are thankful she responded well and the primary site of the cancer shrank by 85%.”
Surgeons then went in to remove as much of it as they could. They managed 95% but the remaining 5% was too close to vital arteries so it was left. Saskia then started the next phase of her treatment. She received a stem cell transplant in which she received a very high dose of chemo followed by a ‘recovery’ of her own stem cells. This took 6 weeks with the time spent in isolation as her immune system was so compromised. Saskia was very weak following the transplant. She lost weight and was unable to walk. After recovering from the transplant, it was then time to start radiotherapy which she’d need every day for three weeks.
Saskia has (almost) finished radiotherapy and is now ready to start immunotherapy for the next six months. Although it appears Saskia is responding well, she is just over half-way through the
treatment and has still a very long journey ahead of her. Full remission for Neuroblastoma cancer is not given until five years after the treatment finishes, as it has such a high relapse rate.
“We’re always anxious about what the future might bring but we’re enormously grateful that Saskia is being treated by the KCC team and benefiting from the results of this study.”
Without partners like ALCCRF who fund ground-breaking research, Saskia would not be benefitting from world class, long-term studies on this hard to treat cancer.
“We are enormously appreciative of the dedication of the Hospital staff, therapists, donors, researchers, and doctors who help treat our daughter and the other kids at the hospital,” says Duane.“Kids cancers we had heard of but knew little about, but now appreciate the dedication of everyone involved and that Saskia’s treatment is the result of the knowledge gained from the treatment of so many kids before Saskia.”